HBIO
Harvard Bioscience, Inc.Healthcare$5.40
◆ Neutral
Mkt Cap: $24.1MFloat: 3.5MSI: 1.4%DTC: 1.4
Data as of market close Apr 7, 2026
IV Rank
-
IV Pctl
-
HV 20d
95.0%
52W Range
$3-$10
ATR(14)
$0.47
Exp. Move
±96.3%
P/C Ratio
0.06
Earnings
May 11
GEX Negative
DEX Long
Net Call Premium
Max Pain Below
Exp. Move Wide
Low Put/Call
HBIO Key Options Data
- Total GEX
- $-0.00B
- Total DEX
- $0.2M
- Max Pain
- $0.50
- Expected Move
- ±96.3%
- Put/Call OI
- 0.06
- Net Premium
- $0.0M
- Spot Price
- $5.40
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 10 | ±$5.20 | ±96.3% | $0.20 | $10.60 |
| 2026-05-15 | 38 | ±$0.07 | ±1.4% | $5.33 | $5.48 |
| 2026-08-21 | 136 | ±$2.40 | ±44.4% | $3.00 | $7.80 |
Explore HBIO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.